Impact of diagnosis and treatment of lung cancer in eighteen months of COVID-19 in Matanzas

Authors

  • Kirenia Camacho-Sosa Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández. Matanzas
  • Luis Enrique Curbelo-Gutiérrez Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández. Matanzas
  • Lisandry Alonso-Lemus Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández. Matanzas https://orcid.org/0000-0002-2986-1790
  • Yudania Vega-Súarez Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández. Matanzas https://orcid.org/0000-0002-5699-1427
  • Tamara Herrera-Álvarez Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández. Matanzas https://orcid.org/0000-0001-5882-7818
  • Esteban Carlos Valenzuela-Cordero Universidad de Ciencias Médicas de Matanzas. Matanzas https://orcid.org/0000-0001-9856-9761

Keywords:

lung cancer, COVID-19, pandemics, impact

Abstract

Introduction: the diagnosis and treatment of lung cancer represents a challenge for society in times of COVID-1 pandemics.

Objective: to analyze the impact of the diagnosis and treatment of lung cancer patients during 18 months of COVID-19 pandemics in Matanzas.

Matertials and methods: an analytical, prospective and longitudinal study was carried out. The universe were 135 patients registered in the Oncology Provincial Service of Matanzas between March 1st 2020 and August 31st 2021. Data were obtained from the clinical records and analyzed with SPSS v.23 statistical packet.

Results: the months with higher quantity of diagnosis were September, October and November. The age with the highest incidence was from 60 to 69 years, with predominance of male sex. In relation to smoking, the highest incidence was represented by smokers (59.2%), and the lowest by non-smokers. Respecting the histological type, the squamous cell carcinoma was the most frequent, and respecting the general status of the patient, the group 1 of the Easter Cooperative Oncology Group was the one with highest prevalence. IV stage was the predominant clinical stage at diagnosis, and chemotherapy and immunotherapy were the most used treatment modalities.

Conclusions: the impact of lung cancer opportune diagnosis and adequate treatment in the first eighteen months of COVID-19 in Matanzas was negative.

Downloads

Download data is not yet available.

References

1. Camacho Sosa K, Ramírez Rodríguez D, Alonso Triana L, et al. Revisión bibliográfica sobre la COVID 19 en pacientes con cáncer de pulmón. Rev Méd Electrón [Internet]. 2021 ene-feb [citado 14/01/2022];43(1):220-31. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3921/5040

2. Castañeda CA, Castillo M, Fuentes H, et al. Covid-19 en pacientes con cáncer: revisión sistemática. Rev Peru Med Exp Salud Pública [Internet]. 2020 [citado 14/01/2022];37(4):611-9. Disponible en: https://siis.unmsm.edu.pe/es/publications/covid-19-in-cancer-patients-a-systematic-review

3. Sánchez-Ríos CP, Ramírez-Candelas MA, Menchaca-Dávila SA, et al. COVID-19: recomendaciones generales y especificaciones para el paciente con cáncer de pulmón avanzado. Revisión de la literatura. Neumol Cir Torax [Internet]. 2020 [citado 14/01/2022];79(2):101-9. Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0028-37462020000200101&script=sci_arttext

4. Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol [Internet]. 2020 [citado 14/01/2022];31(10):1386-96. Disponible en: https://www.annalsofoncology.org/article/S0923-7534(20)39894-X/fulltext

5. Feletto E, Grogan P, Nickson C, et al. How has COVID-19 impacted cancer screening ? Adaptation of services and the future outlook in Australia. Public Heal Res Pr [Internet]. 2020 [citado 14/01/2022];30(4):3042026. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33294902/

6. Fujita K, Ito T, Saito Z, et al. Impact of COVID-19 pandemic on lung cancer treatment scheduling. Thorac Cancer [Internet]. 2020 [citado 21/01/2022];11(10):2983-6. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/1759-7714.13615

7. Mazzone PJ, Gould MK, Arenberg DA, et al. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic. Chest J [Internet]. 2020 [citado 21/01/2022];158(1):406-15. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177089/

8. Singh AP, Berman AT, Marmarelis ME, et al. Management of Lung Cancer During the COVID-19 Pandemic. JCO Oncol Pr [Internet]. 2020 [citado 21/01/2022];16(9):579-86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32453656/

9. Coma E, Guiriguet C, Mora N, et al. Impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia: a time-series analysis of primary care electronic health records covering about five million people. BMJ open [Internet]. 2021 [citado 21/01/2022];11(5):e047567. Disponible en: https://bmjopen.bmj.com/content/11/5/e047567.abstract

10. Alatorre-Alexander JA, Santillán-Doherty P, Martínez-Barrera LM, et al. Descripción clínico-epidemiológica y molecular del cáncer de pulmón en un centro de referencia nacional. NCT Neumol y Cirugía Tórax [Internet]. 2019 [citado 21/01/2022];78(4):356-62. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2019/nt194d.pdf

11. Observatorio Español de las Drogas y las Adicciones. Encuesta OEDA-COVID 2020 [Internet]. Madrid: Ministerio de Sanidad; 2021 [citado 21/01/2022]. Disponible en: https://pnsd.sanidad.gob.es/profesionales/sistemasInformacion/sistemaInformacion/COVID-19/20210326_Informe_ENCUESTA_OEDA-COVID_2020_def.pdf

12. Ettinger DS, Wood DE, Aisner DL, et al. Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw [Internet]. 2022 [citado 21/07/2022];20(5):497-530. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35545176/

13. Leong TL. Acceso retrasado a la detección y el tratamiento del cáncer de pulmón durante la pandemia de COVID-19: ¿Nos dirigimos hacia una pandemia de cáncer de pulmón? Respirology [Internet]. 2021 [citado 21/01/2022];26(2):145-6. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/resp.13996

14. Madan A, Siglin J, Khan A. Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic. Cancer Med [Internet]. 2020 [citado 21/01/2022];9(24):9205-18. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774721/

15. Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol [Internet]. 2020 [citado 21/01/2022];21(8):1023-34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417808/

16. Gurrola-Díaz CM, González-Santiago AE, Troyo-Sanromán R, et al. Tipos histológicos y métodos diagnósticos en cáncer pulmonar en un centro hospitalario de tercer nivel. Gac Med Mex [Internet]. 2009 [citado 21/01/2022];145(2):97-101. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21329

17. Pérez-Cruz PE, Acevedo F. Escalas de estado funcional (o performance status) en cáncer. Gastroenterol latinoam [Internet]. 2014 [citado 21/01/2022];25(3):219-26. Disponible en: https://www.gastrolat.org/DOI/PDF/10.0716/gastrolat2014n300007.pdf

18. Flores Vega YI, Neninger Vinagera E, Páramo González DL, et al. Diagnóstico y tratamiento del cáncer de pulmón. La Habana: Editorial Ciencias Médicas; 2020.

19. London JW, Fazio-Eynullayeva E, Palchuk MB, et al. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. JCO Clin Cancer Inform [Internet]. 2020 [citado 05/02/2022];(4):657-65. Disponible en: http://dx.doi.org/10.1200/CCI.20.00068

20. Patt D, Gordan L, Díaz M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform [Internet]. 2020 [citado 05/02/2022];(4):1059-71. Disponible en: http://dx.doi.org/10.1200/CCI.20.00134

Downloads

Published

2023-04-19

How to Cite

1.
Camacho-Sosa K, Curbelo-Gutiérrez LE, Alonso-Lemus L, Vega-Súarez Y, Herrera-Álvarez T, Valenzuela-Cordero EC. Impact of diagnosis and treatment of lung cancer in eighteen months of COVID-19 in Matanzas. Rev Méd Electrón [Internet]. 2023 Apr. 19 [cited 2025 Feb. 2];45(2):e5034. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/5034

Issue

Vol. 45 No. 2 (2023)

Section

Research article

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.

Most read articles by the same author(s)